Machina Capital’s Tandem Diabetes Care TNDM Stock Holding History

Machina Capital’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100	Closed	-$4.06K	–	510
2023 Q1	$4.06K	Buy	+100	New	+$4.14K	﹤0.01%	444

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Machina Capital's TNDM Position: Q2 2023 in Review

Machina Capital sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 100 shares — an estimated $4.06K sold.

Machina Capital first reported a position in TNDM in Q1 2023 and held it in 1 quarter. The position peaked at $4.06K in Q1 2023. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

Machina Capital reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
Machina Capital sold 100 Tandem Diabetes Care shares in Q2 2023, an estimated $4.06K.
Machina Capital first reported a position in Tandem Diabetes Care in Q1 2023 and held it in 1 quarter.
Machina Capital's Tandem Diabetes Care position peaked at $4.06K in Q1 2023.
247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Machina Capital's 13F filing for Q2 2023, filed 8 Aug 2023.